Using an AI robot to reduce urinary tract infections in bedridden women
Testing the Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections, Incontinence-associated Dermatitis and Caregiving Costs for Incontinence Patients
This study is testing whether an AI robot can help reduce urinary tract infections in women who are bedridden by managing their hygiene needs.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 20 Years and up |
| Sex | Female |
| Sponsor | China Medical University Hospital Academic / other |
| Locations | 1 site (Taichung) |
| Trial ID | NCT06613503 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the 'AI Supporter,' an intelligent robot designed to manage excretion for bedridden patients. The robot uses artificial intelligence to detect and clean affected areas, change diapers, and dry the skin, aiming to reduce urinary tract infections and incontinence-associated dermatitis. The research will involve 60 female participants who have been bedridden for over three months, using the AI Supporter intermittently over a 14-day period. The study will also assess the cost-effectiveness of this technology in long-term care settings.
Who should consider this trial
Good fit: Ideal candidates are female patients over 20 years old who have been bedridden for at least three months and experience urinary and/or fecal incontinence.
Not a fit: Patients with severe skin conditions unrelated to incontinence or those currently suffering from urinary tract infections or dermatitis may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the incidence of urinary tract infections and improve the quality of care for incontinent patients.
How similar studies have performed: While the use of AI in caregiving is an emerging field, similar studies have shown promise in improving care quality and reducing caregiver strain, making this approach both innovative and relevant.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must have been bedridden for at least 3 months and have urinary and/or fecal incontinence. * Female participants aged over 20 years old. * Participants must be capable of wearing the AI-supporter device during the study period. Exclusion Criteria: * Participants with severe skin conditions unrelated to incontinence. * Participants with current urinary tract infections or incontinence-associated dermatitis at the time of enrollment. * Participants who are unable to provide informed consent or have a legal representative to do so.
Where this trial is running
Taichung
- Rom A Master List, Extracted From This Organization'S Records. — Taichung, Taiwan (Recruiting)
Study contacts
- Study coordinator: Kwo-Chen Lee, ph.D
- Email: rubylee@mail.cmu.edu.tw
- Phone: 886422053366
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.